MAbs
Efficient brain delivery and sustained retention of antibodies via dual targeting of blood-brain barrier and intra-brain proteins
Experiments in animalsInterventions
The paper
Chugai Pharmaceutical Co., Ltd. (Japan)
MAbs, 28 Aug 2026
Chugai Pharmaceutical Co., Ltd. (Japan)
MAbs, 28 Aug 2026
Neurobiology of Disease10 Oct 2026

Research Square10 Oct 2026

PNAS10 Oct 2026

Aging Cell9 Oct 2026
